Cargando…

Susceptibility to Plasmodium vivax malaria associated with DARC (Duffy antigen) polymorphisms is influenced by the time of exposure to malaria

Malaria has provided a major selective pressure and has modulated the genetic diversity of the human genome. The variants of the Duffy Antigen/Receptor for Chemokines (DARC) gene have probably been selected by malaria parasites, particularly the FY*O allele, which is fixed in sub-Saharan Africa and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kano, Flora Satiko, de Souza, Aracele Maria, de Menezes Torres, Leticia, Costa, Marcelo Azevedo, Souza-Silva, Flávia Alessandra, Sanchez, Bruno Antônio Marinho, Fontes, Cor Jesus Fernandes, Soares, Irene Silva, de Brito, Cristiana Ferreira Alves, Carvalho, Luzia Helena, Sousa, Tais Nobrega
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138695/ https://www.ncbi.nlm.nih.gov/pubmed/30218021 http://dx.doi.org/10.1038/s41598-018-32254-z

Ejemplares similares

Plasmodium simium, a Plasmodium vivax-Related Malaria Parasite: Genetic Variability of Duffy Binding Protein II and the Duffy Antigen/Receptor for Chemokines
por: Camargos Costa, Daniela, et al.
Publicado: (2015)

The Duffy binding protein as a key target for a Plasmodium vivax vaccine: lessons from the Brazilian Amazon
por: de Sousa, Taís Nóbrega, et al.
Publicado: (2014)

Duffy Antigen Receptor for Chemokine (DARC) Polymorphisms and Its Involvement in Acquisition of Inhibitory Anti-Duffy Binding Protein II (DBPII) Immunity
por: Souza-Silva, Flávia A., et al.
Publicado: (2014)

Worldwide Genetic Variability of the Duffy Binding Protein: Insights into Plasmodium vivax Vaccine Development
por: Nóbrega de Sousa, Taís, et al.
Publicado: (2011)

Distinct HLA class II alleles influence antibody response to the Plasmodium vivax Duffy binding protein
por: Kano, Flora S, et al.
Publicado: (2014)

Multiple-clone infections of Plasmodium vivax: definition of a panel of markers for molecular epidemiology
por: de Souza, Aracele M., et al.
Publicado: (2015)

Ribosomal and non-ribosomal PCR targets for the detection of low-density and mixed malaria infections
por: Amaral, Lara Cotta, et al.
Publicado: (2019)

The Presence, Persistence and Functional Properties of Plasmodium vivax Duffy Binding Protein II Antibodies Are Influenced by HLA Class II Allelic Variants
por: Kano, Flora S., et al.
Publicado: (2016)

Plasmodium vivax infection: atypical memory B cells are expanded and associated with the persistence of Duffy binding protein II (DBPII) antibody response
por: Kano, Flora S, et al.
Publicado: (2014)

Genetic variability and natural selection at the ligand domain of the Duffy binding protein in brazilian Plasmodium vivax populations
por: Sousa, Taís N, et al.
Publicado: (2010)

The Duffy Antigen Receptor for Chemokines DARC/ACKR1
por: Horuk, Richard
Publicado: (2015)

Population genetic analysis of the DARC locus (Duffy) reveals adaptation from standing variation associated with malaria resistance in humans
por: McManus, Kimberly F., et al.
Publicado: (2017)

Plasma Circulating Nucleic Acids Levels Increase According to the Morbidity of Plasmodium vivax Malaria
por: Franklin, Bernardo S., et al.
Publicado: (2011)

Acquired Antibody Responses against Plasmodium vivax Infection Vary with Host Genotype for Duffy Antigen Receptor for Chemokines (DARC)
por: Maestre, Amanda, et al.
Publicado: (2010)

Vivax malaria in Mauritania includes infection of a Duffy-negative individual
por: Wurtz, Nathalie, et al.
Publicado: (2011)

Assessment of copy number variation in genes related to drug resistance in Plasmodium vivax and Plasmodium falciparum isolates from the Brazilian Amazon and a systematic review of the literature
por: Costa, Gabriel Luíz, et al.
Publicado: (2017)

Molecular epidemiology of Plasmodium vivax and Plasmodium falciparum malaria among Duffy-positive and Duffy-negative populations in Ethiopia
por: Lo, Eugenia, et al.
Publicado: (2015)

Is zoonotic Plasmodium vivax malaria an obstacle for disease elimination?
por: Chaves, Bárbara Aparecida, et al.
Publicado: (2022)

The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor
Publicado: (1995)

Presence of additional Plasmodium vivax malaria in Duffy negative individuals from Southwestern Nigeria
por: Oboh, Mary Aigbiremo, et al.
Publicado: (2020)

A systematic scoping review of the genetic ancestry of the Brazilian population
por: de Souza, Aracele Maria, et al.
Publicado: (2019)

Plasmodium simium/Plasmodium vivax infections in southern brown howler monkeys from the Atlantic Forest
por: Costa, Daniela Camargos, et al.
Publicado: (2014)

Vivax malaria in Duffy-negative patients shows invariably low asexual parasitaemia: implication towards malaria control in Ethiopia
por: Abate, Andargie, et al.
Publicado: (2022)

Adherence to Plasmodium vivax malaria treatment in the Brazilian Amazon Region
por: Pereira, Elza A, et al.
Publicado: (2011)

Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean
por: Grann, Victor R, et al.
Publicado: (2008)

Natural Selection Mediated Association of the Duffy (FY) Gene Polymorphisms with Plasmodium vivax Malaria in India
por: Chittoria, Anita, et al.
Publicado: (2012)

Asymptomatic Plasmodium vivax malaria in the Brazilian Amazon: Submicroscopic parasitemic blood infects Nyssorhynchus darlingi
por: Almeida, Gregório Guilherme, et al.
Publicado: (2021)

Duffy blood group gene polymorphisms among malaria vivax patients in four areas of the Brazilian Amazon region
por: Cavasini, Carlos E, et al.
Publicado: (2007)

Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses
por: Silvino, Ana Carolina Rios, et al.
Publicado: (2016)

Molecular Evidence of Plasmodium vivax Mono and Mixed Malaria Parasite Infections in Duffy-Negative Native Cameroonians
por: Ngassa Mbenda, Huguette Gaelle, et al.
Publicado: (2014)

An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies
por: Ntumngia, Francis B., et al.
Publicado: (2017)

Correction: Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses
por: Silvino, Ana Carolina Rios, et al.
Publicado: (2018)

A Novel Erythrocyte Binding Protein of Plasmodium vivax Suggests an Alternate Invasion Pathway into Duffy-Positive Reticulocytes
por: Ntumngia, Francis B., et al.
Publicado: (2016)

Multiple-Clone Activation of Hypnozoites Is the Leading Cause of Relapse in Plasmodium vivax Infection
por: de Araujo, Flávia Carolina F., et al.
Publicado: (2012)

Duffy Blood Group System and the malaria adaptation process in humans
por: de Carvalho, Gledson Barbosa, et al.
Publicado: (2011)

Structural basis for DARC binding in reticulocyte invasion by Plasmodium vivax
por: Moskovitz, Re’em, et al.
Publicado: (2023)

Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis
por: Addison, Christina L, et al.
Publicado: (2004)

Neutrophil Effector Functions Are Not Impaired in Duffy Antigen Receptor for Chemokines (DARC)-Null Black South Africans
por: Naidoo, Kewreshini K., et al.
Publicado: (2019)

Selective Intermittent Preventive Treatment of Vivax Malaria: Reduction of Malaria Incidence in an Open Cohort Study in Brazilian Amazon
por: Katsuragawa, Tony Hiroshi, et al.
Publicado: (2013)

Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection
por: Hou, Mimi M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q59r0vg9dtb0q6drffcukg0qp0